iValue 
Dealstreet

CAM, Trilegal act on iValue Infosolutions ~₹560 crore IPO

iValue is a technology solutions provider focused on managing digital applications and data.

Bar & Bench

iValue Infosolutions Limited has made an initial public offering aggregating to ₹560.295 crore, which comprises of an offer for sale by certain existing shareholders.

Cyril Amarchand Mangaldas advised iValue Infosolutions on this IPO.

The transaction team was led by Ravi Kumar Dubey (Partner, Regional Co-head, Capital Markets West) and Anshul Roy (Partner), with assistance from Radhika Pandey (Principal Associate), Sravya Surapaneni (Senior Associate), Associates Bhaskar Kumar, Aniruddh Saraswat, Anomitra Debnath, and Rakshitha V.

Ravi Dubey, Anshul Roy

Trilegal is advising IIFL Securities Limited and Motilal Oswal Investment Advisors Limited, the book running lead managers to this IPO.

The transaction team was led by Richa Choudhary (Partner), with support from Avanti Kale (Counsel), Maitreya Rajurkar (Counsel), Pooja Tada (Senior Associate), Shivayana Balodia (Senior Associate) and Associates Kartikeya Anshu, Hemant Sangwan, and Adya Singh.

Richa Choudhary

iValue is a technology solutions provider focused on managing digital applications and data and offers security analytics, network security, application management and cloud integration services. It is backed by marquee investor, Creador, who is also one of the selling shareholders.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Hiding live-in relationship, child from prospective bride amounts to offence of sex by deceitful means: Kerala High Court

Delhi High Court restrains piracy websites from streaming Drishyam: The Conclusion

Lawyer engaged by statutory body can't hand over brief to junior and stop appearing: NCLAT

Maharashtra has most Maoist frontal groups: State defends Special Public Security Act in Bombay High Court

Delhi court flags ‘serious lapse’ after NCB's Chandigarh and Delhi units fail to cooperate in drug probe

SCROLL FOR NEXT